Skip to main content
Download PDF

Serum cystatin C and inflammatory factors related to COVID-19 consequences

BMC Infectious Diseases volume 23, Article number: 339 (2023) Cite this article

Abstract

Background

Besides impaired respiratory function and immune system, COVID-19 can affect renal function from elevated blood urea nitrogen (BUN) or serum creatinine (sCr) levels to acute kidney injury (AKI) and renal failure. This study aims to investigate the relationship between Cystatin C and other inflammatory factors with the consequences of COVID-19.

Methods

A total of 125 patients with confirmed Covid-19 pneumonia were recruited in this cross-sectional study from March 2021 to May 2022 at Firoozgar educational hospital in Tehran, Iran. Lymphopenia was an absolute lymphocyte count of less than 1.5 × 109/L. AKI was identified as elevated serum Cr concentration or reduced urine output. Pulmonary consequences were evaluated. Mortality was recorded in the hospital one and three months after discharge. The effect of baseline biochemical and inflammatory factors on odds of death was examined. SPSS, version 26, was used for all analyses. P-vale less than 0.05 was considered significant.

Results

The highest amount of co-morbidities was attributed to COPD (31%; n = 39), dyslipidemia and hypertension (27%; n = 34 for each) and diabetes (25%; n = 31). The mean baseline cystatin C level was 1.42 ± 0.93 mg/L, baseline creatinine was 1.38 ± 0.86 mg/L, and baseline NLR was 6.17 ± 4.50. Baseline cystatin C level had a direct and highly significant linear relationship with baseline creatinine level of patients (P < 0.001; r: 0.926). ). The average score of the severity of lung involvement was 31.42 ± 10.80. There is a direct and highly significant linear relationship between baseline cystatin C level and lung involvement severity score (r = 0.890, P < 0.001). Cystatin C has a higher diagnostic power in predicting the severity of lung involvement (B = 3.88 ± 1.74, p = 0.026). The mean baseline cystatin C level in patients with AKI was 2.41 ± 1.43 mg/L and significantly higher than patients without AKI (P > 0.001). 34.4% (n = 43) of patients expired in the hospital, and the mean baseline cystatin C level of this group of patients was 1.58 ± 0.90 mg/L which was significantly higher than other patients (1.35 ± 0.94 mg/L, P = 0.002).

Conclusion

cystatin C and other inflammatory factors such as ferritin, LDH and CRP can help the physician predict the consequences of COVID-19. Timely diagnosis of these factors can help reduce the complications of COVID-19 and better treat this disease. More studies on the consequences of COVID-19 and knowing the related factors will help treat the disease as well as possible.

Peer Review reports

Introduction

In March 2020, the World Health Organization (WHO) confirmed and announced the pandemic and globalization of COVID-19, involving more than 195 countries worldwide. This disease is very contagious, and human-to-human transmission is unfortunately very high. To control this problem, different countries formulated and implemented different quarantine, military, and city protocols to control the movement of citizens.

COVID-19 has manifested in a wide spectrum, from asymptomatic infection to critical pneumonia with acute respiratory distress syndrome (ARDS) [1]. For this reason, multiple organ dysfunctions and mortality are very high, especially in adults with comorbidities [2, 3]. Terrible cytokine storm can make the situation of COVID-19 dangerous due to overactive inflammation and immune response [4]. Besides impaired respiratory function and immune system, COVID-19 can affect renal function from elevated blood urea nitrogen (BUN) or serum creatinine (sCr) levels to acute kidney injury (AKI) and renal failure [5]. Most nucleated cells secret Cystatin C, a cysteine protease inhibitor to blood circulation, and evidence shows that Cystatin C directly interacts with human coronaviruses [6]. Considering that it is not affected by ingestion of meat and no tubular secretion of cystatin, it is a more sensitive biomarker for early kidney impairment than conventional indicators such as BUN and sCr [7].

Ferritin, C-reactive protein (CRP), lactate dehydrogenase (LDH), sCr, and neutrophil to lymphocyte ratio (NLR) were other inflammatory factors investigated. Retrospective analyses found that CRP, ferritin, and LDH were higher in patients who died than in survivors [8, 9].

Through direct immune-suppressive and pro-inflammatory effects, Ferritin has a key role in the dysregulation of the immune system, especially under extreme hyperferritinemia [10]. Results of some studies showed that serum ferritin levels were closely related to the severity of COVID-19 [11,12,13,14].

NLR is one routinely available marker of the systemic inflammatory response, which is obtained by dividing the absolute count of neutrophils into the absolute count of lymphocytes in whole blood. Increasing NLR is a mortality risk factor not only in infectious diseases like COVID-19 but also in cancer, acute coronary syndrome, intracerebral hemorrhage, polymyositis, and dermatomyositis [15,16,17,18]. There is evidence that patients with severe COVID-19 have higher NLR [19], and more studies are needed to reveal the role of these inflammatory factors in predicting the events caused by COVID-19.

This study aims to investigate the relationship between Cystatin C and other inflammatory factors with the consequences of COVID-19.

Materials and methods

The present study was done as cross-sectional in a single center from March 2021 to May 2022 at Firoozgar educational hospital in Tehran, Iran. A total of 125 patients 16 to 80 years old with moderate to severe confirmed COVID-19, according to WHO interim guidance [20], were recruited in this study.

This study was approved by the Ethics Committee of the Iran University of Medical IR.IUMS.FMD.REC.1401.068, all patients or first-degree family members signed written informed consent. Smoking status, body mass index (BMI), marital status, and past medical histories like diabetes, hypertension, and dyslipidemia were recorded. Ferritin, C-reactive protein (CRP), Lactate dehydrogenase (LDH), creatinine, and neutrophil to lymphocyte ratio (NLR) were defined.

Lymphopenia was an absolute lymphocyte count of less than 1.5 × 109/L. AKI was identified as elevated serum Cr concentration or reduced urine output. AKI currently defines by a rise from baseline of at least 0.3 mg/dl within 48 h or at least 50% higher than baseline within 1 week, or a reduction in urine output to < 0.5 ml/kg per hour for longer than 6 h [21].

Pulmonary consequences were assessed by rapid shallow breathing index (RSBI), Pressure of Arterial Oxygen to Fractional Inspired Oxygen Concentration (Pao2/Fio2 ratio), Fractional Inspired Oxygen Concentration (FIO2), Oxygen saturation, and respiratory rate. AKI was identified as a renal consequence of COVID-19.

Mortality was recorded in the hospital one and three months after discharge. The effect of baseline biochemical and inflammatory factors on odds of death was examined.

Statistical analysis

Continuous measurements were reported as mean ± Standard deviation (SD) for normally distributed data, and categorical variables were described as several patients (percent). Continuous variables were compared using an independent sample t-test or Mann-Whitney test based on normality, and proportions for categorical variables were compared using the χ2 test. In contrast, the Fisher exact test was conducted when the data were limited. Spearman test was used for analyzing bivariate correlation. Logistic regression was used to evaluate the incidence of AKI and in-hospital death. A generalized linear model was used to show the simultaneous effect of baseline cystatin C and creatinine values on the severity of lung involvement. Our analysis used a 95% confidence interval to express the association’s severity. SPSS, version 26, was used for all analyses. P-vale less than 0.05 was considered significant.

Results

The present study shows clinical information of 125 hospitalized COVID-19 patients. The mean age of patients was 51.93 ± 19.5 years old. The most of patients were male (57%; n = 71) and married (57%; n = 71). The mean BMI was 26.34 ± 5.4. The highest amount of co-morbidities was attributed to COPD (31%; n = 39), dyslipidemia and hypertension (27%; n = 34 for each) and diabetes (25%; n = 31). Table 1.

Table 1 Basic characteristics of Covid-19 patients who are ICU admitted at Firoozgar Hospital
Full size table

The mean baseline cystatin C level was 1.42 ± 0.93 mg/L, baseline creatinine was 1.38 ± 0.86 mg/L, and baseline NLR was 6.17 ± 4.50. The level of other biochemical and respiratory indicators is illustrated in Table 2.

Table 2 Biochemical and respiratory indexes of Covid-19 patients
Full size table

The results of Spearman’s correlation coefficient test show that baseline cystatin C level has a direct and highly significant linear relationship with baseline creatinine level of patients (P < 0.001; r: 0.926). ). The relationship between baseline cystatin C level and baseline level of other inflammatory factors was not significant, Table 3.

Table 3 Correlation of Cystatin C and baseline values of Biochemical and inflammatory factors*
Full size table

Lymphopenia was reported in 41.6% (n = 52). The mean baseline cystatin C level in patients with lymphopenia was 1.20 ± 0.45 mg/L and had no significant difference from other patients (P = 0.182). The baseline level of other inflammatory factors, including creatinine, ferritin, NLR, LDH, and CRP, according to lymphopenia, is shown in Table 4. As indicated, the average level of ferritin, NLR, and CRP in patients with lymphopenia was significantly higher than in other patients.To identify possible confounding variables, the demographic and clinical characteristics of patients with and without lymphopenia are compared in Table 4. The mean age of patients with lymphopenia was 63.50 ± 16.92 years which was about 20 years higher than the average age (43.69 ± 16.94) in people who did not have lymphopenia (p < 0.001).

Table 4 Baseline level of Biochemical and inflammatory factors and Demographic and clinical characteristics of patients according to lymphopenia
Full size table

Moreover, patients with lymphopenia were overweight (mean of BMI = 27.95 ± 5.51 kg/m2), while other patients were almost not overweight (25.19 ± 5.11 kg/m2) (p = 0.007). Most patients in both groups were men (P = 0.574). Comparing the distribution of comorbidities in two groups, a significant difference was observed in cardiovascular disease and asthma. Several patients with cardiovascular disease were reported more in the group with lymphopenia, while this number was lower in the case of asthma. On the other hand, considering that no significant relationship was observed between the demographic and clinical factors of the patients with ferritin, NLR, and CRP, it was not necessary to repeat the analysis to control the confounding variables.

The average score of the severity of lung involvement was 31.42 ± 10.80. Also, there is a direct and highly significant linear relationship between baseline cystatin C level and lung involvement severity score (r = 0.890, P < 0.001). The correlation between the severity of lung involvement and the baseline values of other inflammatory factors, including creatinine, ferritin, NLR, LDH, and CRP, are shown in Table 5. It was significant only in the case of creatinine (r = 0.851, p < 0.001).

Table 5 Correlation of basic values of inflammatory factors and lung involvement severity score*
Full size table

The simultaneous effect of baseline cystatin C and creatinine values on the severity of lung involvement were evaluated using a generalized linear model. Results showed that baseline cystatin C has a higher diagnostic power in predicting the severity of lung involvement (B = 3.88 ± 1.74, p = 0.026). So, for each one unit increase in the baseline values of cystatin C and creatinine, the average score of the severity of lung involvement will increase by 14 and 11 units, respectively (p < 0.001 for both).

Out of 125 patients, 53% (n = 66) were intubated and 47% (n = 59) were not intubated. The mean baseline cystatin C level in intubated patients was 1.48 ± 1.09 mg/L and in non-intubated patients was 1.35 ± 0.69 mg/L. And in this regard, there was no significant difference between the two groups of patients (P = 0.899).

The analysis of the basic values of other inflammatory factors, including creatinine, ferritin, NLR, LDH, and CRP, according to the intubation status of the patients, is shown in Table 6. As can be seen, the average level of ferritin, LDH, and CRP in intubated patients was significantly higher than in other patients.To identify possible confounding variables, the demographic and clinical characteristics of patients with and without intubation are compared in Table 6. The mean age of intubated patients was about 8 years, and the mean BMI was about 3 units higher than non-intubated patients (P-value equal to 0.017 and < 0.001, respectively). Comparing the comorbidities distribution in these two groups of patients was significant in terms of dyslipidemia and cardiovascular disease. So, the number of patients with dyslipidemia and cardiovascular disease in intubated patients was 38% and 33%, respectively, and in non-intubated patients, 15% and 12%, respectively (P-value in both comparisons equal to 0.005).

Table 6 Baseline level of biochemical and inflammatory factors and Demographic and clinical characteristics according to intubation*
Full size table

On the other hand, the relationship between demographic and clinical factors of patients with ferritin, NLR, and CRP was significant only for CRP and dyslipidemia (P = 0.020). So the mean CRP in patients with dyslipidemia was 102.85 ± 50.50 mg/dl; in other patients, it was 85.14 ± 59.14.

Based on this, using logistic regression, the relationship between CRP and intubation status was still significant by adjusting the patients’ dyslipidemia status as a confounding variable. By keeping other conditions constant, for each unit increase in CRP, the chance of intubation increased by 1.02 times (P < 0.001). Moreover, keeping other conditions constant, the chance of intubation in patients with dyslipidemia was significantly 2.82 times that of patients without dyslipidemia (P = 0.033).

The average ventilation time of intubated patients was 2.72 days, and the relationship between baseline cystatin C level and the average ventilation time of intubated patients was insignificant (r=-0.162, P = 0.195). However, the average ventilation time of intubated patients showed a direct and incomplete linear relationship with the baseline values of NLR and CRP (P-value equal to 0.012 and 0.024, respectively), Table 7.

Table 7 Correlation of basic values of inflammatory factors and ventilation time*
Full size table

The acute kidney injury (AKI) report was positive in 11% of patients (n = 14). The mean baseline cystatin C level in patients with AKI was 2.41 ± 1.43 mg/L and significantly higher than patients without AKI (P > 0.001).

Baseline values of other inflammatory factors, including creatinine, ferritin, NLR, LDH, and CRP, according to AKI status, are shown in Table 8. Among the above factors, the average baseline creatinine level in patients with AKI was significantly higher by 1.27 units than in other patients (P < 0.001).

Table 8 Baseline level of biochemical and inflammatory factors according to AKI status*
Full size table

The average hospitalization duration of the patients was 10.70 ± 5.74 days, and there was no significant relationship between the baseline cystatin C level of the patients and hospitalization duration (r=-0.049, P = 0.586). A direct and incomplete linear relationship was observed between ferritin (r = 0.219, P = 0.014) and CRP (r = 0.241, P = 0.007) with hospitalization duration.

34.4% (n = 43) of patients expired in the hospital, and the mean baseline cystatin C level of this group of patients was 1.58 ± 0.90 mg/L which was significantly higher than other patients (1.35 ± 0.94 mg/L, P = 0.002). Moreover the mean baseline values of creatinine (1.32 ± 0.89 mg/L vs. 1.49 ± 0.78 mg/L, p = 0.012), ferritin (4.98 ± 3.45 mg/L vs. 8.69 ± 4.19 mg/L, p < 0.001), LDH (5.91 ± 2.49 mg/L vs. 8.29 ± 3.73 mg/L, p < 0.001) and CRP (76.54 ± 57.18 mg/L vs. 115.53 ± 48.55 mg/L, p < 0.001) in patients who died in the hospital was significantly higher than other patients.

Backward logistic regression analysis showed that the simultaneous effect of baseline values of cystatin C, creatinine, ferritin, LDH, and CRP on the occurrence of death in the hospital only remained significant for ferritin and LDH; So that for each unit of increase in baseline values of ferritin and LDH, the chance of dying in the hospital increased one-fold (P-value < 0.001 and 0.010 respectively), Table 9.

Table 9 Effect of baseline biochemical and inflammatory factors on in-hospital death*
Full size table

To identify possible confounding variables, the demographic and clinical characteristics of patients who died in the hospital are compared with other patients. Considering that there was no significant difference between the two groups of patients in terms of demographic and clinical characteristics, it was not necessary to repeat the analysis in an adapted manner to check the relationship between the baseline values of cystatin C and other inflammatory factors.

Among the 82 patients discharged from the hospital, 9.75% (n = 8) expired within one month after discharge. The average baseline cystatin C level of this group of patients was 1.58 ± 1.68 mg/L, which was not significantly different from the level of patients who survived during this period (1.41 ± 0.86 mg/L, P = 0.593). Comparing the mean values of other inflammatory factors in patients who died within one month after discharge with those who survived showed that it was significant only in ferritin (P = 0.004). The mean baseline ferritin level in patients who died within one month after discharge was about 4 units higher than in patients who survived during this period (8.38 ± 2.45 mg/L vs. 4.61 ± 3.35 mg/L, respectively).

Among the 74 patients who survived one month after discharge from the hospital, 4 patients (5%) died within 3 months after discharge. The average baseline cystatin C level of this group of patients was 1.00 ± 0.021 mg/L was not significantly different from the patients who survived during this period (1.44 ± 0.94 mg/L, P = 0.510). Other inflammatory factors were not significantly different between the two groups.

In the investigation of the relationship between baseline values ​​of cystatin C and other inflammatory factors with death within one month and 3 months after discharge, there was not enough sample in the subgroup of expired patients to compare with alive patients. Therefore the observed relationship is subject to random error.

The relationship between cystatin C level and baseline respiratory factors of patients showed that there is only a direct and incomplete linear relationship between baseline breathing rate and cystatin C level (r = 0.202, P = 0.024).

Generalized linear models (GLM) showed that for each unit increase in the baseline breathing rate, the breathing rate of the patients increased by 0.23 units in the follow-up measurement.

Results showed no correlation between baseline cystatin C level and follow-up respiratory factors, Table 10.

Table 10 Correlation of follow-up values of respiratory indexes and Cystatin C*
Full size table

Discussion

The present cross-sectional study revealed several factors related to COVID-19 consequences. Among factors, cystatin C had a direct and highly significant linear relationship with lung involvement severity score. Besides cystatin C, creatinine is also significantly associated with lung involvement severity score. However, compared with creatinine, cystatin C had a higher diagnostic power to predict the severity of lung involvement. So for each one unit increase in the baseline values of cystatin C and creatinine, the average score of the severity of lung involvement will increase by 14 and 11 units, respectively. A recent study by Chen et al. [22] investigated the value of cystatin C for predicting the prognosis of COVID-19 patients. Their study showed that increases in cystatin C were associated with long-term lung damage. In confirming the results of a study done by Chen and our study, another study also showed similar results in COVID-19 patients. A total of 273 COVID-19 patients enrolled with imaging progression in the Yang study. The result showed that parameters including homocysteine, urea, creatinine, and serum cystatin C were significantly higher in imaging progression patients [23].

Among 125 patients who participated in this study, 53% were intubated, and the present study showed that ferritin, CRP, and LDH as inflammatory factors were significantly higher in intubated patients than in others. Recently, a published study investigated the difference in the basic factors and consequences of COVID-19 according to the time of intubation. This study divided patients into “early intubation” and “late intubation”. Early intubated patients (defined as intubation between 4 and 24 h after admission to the hospital) had a lower ferritin level than late intubation patients (intubation between 5 and 10 days after admission). At the same time, CRP was higher in that group of patients [24].

In the present study, body mass index (BMI) was about 3 units higher in intubated patients than non-intubated patients. The data from another research [25] showed that patients with higher BMI have more respiratory distress on hospital admission (increased dyspnea, need for supplemental oxygen, and higher respiratory rate) and higher intubation rates. These data confirm the hypothesis that a greater degree of respiratory compromise in patients with COVID-19 is related to obesity.

Although obesity and metabolic syndrome have been related to Immune system disorders and a higher risk of pneumonia [26, 27], the impact of obesity on COVID-19 severity has not yet been fully determined. Impaired respiratory mechanics, restrictive lung physiology caused by excess body weight, and poor pulmonary reserve may play a role in the effect of obesity on severe respiratory distress in patients with COVID-19 [26,27,28,29].

Results of our study showed that the average ventilation time of intubated patients has a direct and incomplete linear relationship with the baseline level of NLR and CRP. Several studies [30, 31] that investigated prediction risk scores for ventilation in patients with COVID-19 revealed that CRP could predict the need for ventilation in these patients. These results were in line with the results of the present study. Moreover, other studies [9, 32, 33] illustrated that NLR is a good predictor of mechanical ventilation in patients with COVID-19. Another study in China indicated that high NLR > 3.13 in a company with a high cytokine response could be a good indicator of the exacerbating clinical condition of patients with COVID-19 [34].

Many studies have been conducted on the predictive power of cystatin C and creatinine for the occurrence of AKI. One of these studies is a meta-analysis that analyzed the results of 19 studies [35]. The diagnostic odds ratio (OR) for serum cystatin C level to predict AKI was 23.5. Results of that study declare that serum cystatin C is a good biomarker in predicting AKI. In the present study, we found that cystatin C and creatinine were significantly higher in patients with AKI compared to other patients. Still, none of the two mentioned factors significantly predicted the chance of AKI occurrence. It should be noted that the significant result observed between baseline values ​​of cystatin C and creatinine with the occurrence of AKI in patients can be caused by random error due to the very small sample size in the subgroup of patients with AKI. For this reason, the distribution of demographic and clinical characteristics to identify potential confounding variables according to AKI status was not sufficiently powerful in the current study. Therefore, it is necessary to investigate the relationship observed in this study in future studies with a sufficient sample size and by controlling possible confounders.

The predictive value of cystatin C in the prognosis of patients with COVID-19 is rarely reported, but some studies have confirmed that cystatin C can predict the risk of death in patients with COVID-19 [5, 36,37,38]. In our study, 34% of patients with COVID-19 expired in the hospital, and the baseline cystatin C level of these patients was significantly higher than alive patients. In addition to cystatin C, a baseline level of creatinine, CRP, ferritin, and LDH is higher in expired patients than in others. The Xiang study showed that patients with severe COVID-19 had a high level of biochemical indicators of renal function like BUN, cystatin C, and creatinine, indicating kidney damage [39]. Besides Xiang’s study, other studies have also shown the occurrence of kidney disorders in COVID-19 disease [36, 40, 41]. The incidence of AKI in patients with COVID-19 has been reported from 0.9 to 29% [9, 13, 42]. An acute proximal renal tubular injury characterized by loss of brush margin, vacuolar degeneration, dilation of the tubular lumen with cell fragments, necrosis, and epithelial exfoliation has been seen in patients with COVID-19 [41]. The total mortality rate of patients with renal involvement was significantly higher than that of other patients without renal involvement (11.2% vs. 1.2%, respectively) (42), proposing that the mortality rate of COVID-19 may be related to renal involvement.

Conclusion

In conclusion, cystatin C and other inflammatory factors such as ferritin, LDH and CRP can help the physician predict the consequences of COVID-19. Timely diagnosis of these factors can help reduce the complications of COVID-19 and better treat this disease. More studies on the consequences of COVID-19 and knowing the related factors will help treat the disease as well as possible.

Data availability

The datasets used during the current study are available from the corresponding author on reasonable request.

References

  1. Pan Y, Yu X, Du X, Li Q, Li X, Qin T, Wang M, Jiang M, Li J. Li WJTJoid: Epidemiological and clinical characteristics of 26 asymptomatic severe acute respiratory syndrome coronavirus 2 carriers. 2020, 221(12):1940–7.

  2. Yang X, Yu Y, Xu J, Shu H, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu TJTLRM. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. 2020, 8(5):475–81.

  3. Contou D, Claudinon A, Pajot O, Micaëlo M, Longuet Flandre P, Dubert M, Cally R, Logre E, Fraissé M. Mentec HJAoic: Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU. 2020, 10(1):1–9.

  4. Jose RJ, Manuel AJTLRM. COVID-19 cytokine storm: the interplay between inflammation and coagulation. 2020, 8(6):e46–7.

  5. Lin L, Chen X, Chen J, Pan X, Xia P, Lin H. Du HJSr: The predictive value of serum level of cystatin C for COVID-19 severity. 2021, 11(1):1–8.

  6. Zi M, Xu YJIl. Involvement of cystatin C in immunity and apoptosis. 2018, 196:80–90.

  7. Coll E, Botey A, Alvarez L, Poch E, Quintó L, Saurina A, Vera M, Piera C. Darnell AJAjokd: Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. 2000, 36(1):29–34.

  8. Ruan Q, Yang K, Wang W, Jiang L, Song JJIcm. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. 2020, 46(5):846–8.

  9. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J. Gu XJTl: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. 2020, 395(10223):497–506.

  10. Abbaspour N, Hurrell R, Kelishadi, RJJorimstojoIUoMS. Review on iron and its importance for human health. 2014, 19(2):164.

  11. Zhou B, She J, Wang Y, Ma X. Utility of ferritin, procalcitonin, and C-reactive protein in severe patients with 2019 novel coronavirus disease. 2020.

  12. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B. Gu XJTl: Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. 2020, 395(10229):1054–62.

  13. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y. Wei YJTl: Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. 2020, 395(10223):507–13.

  14. Fox SE, Akmatbekov A, Harbert JL, Li G, Brown JQ, Vander Heide RSJTLRM. Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans. 2020, 8(7):681–686.

  15. Azab B, Zaher M, Weiserbs KF, Torbey E, Lacossiere K, Gaddam S, Gobunsuy R, Jadonath S, Baldari D. McCord DJTAjoc: Usefulness of neutrophil to lymphocyte ratio in predicting short-and long-term mortality after non–ST-elevation myocardial infarction. 2010, 106(4):470–6.

  16. Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC. Clarke SJJCrioh: The systemic inflammation-based neutrophil–lymphocyte ratio: experience in patients with cancer. 2013, 88(1):218–30.

  17. Giede-Jeppe A, Bobinger T, Gerner ST, Sembill JA, Sprügel MI, Beuscher VD, Lücking H, Hoelter P, Kuramatsu JB, Huttner HBJCD. Neutrophil-to-lymphocyte ratio is an independent predictor for in-hospital mortality in spontaneous intracerebral hemorrhage. 2017, 44(1–2):26–34.

  18. Samaneh Y, ShahidehJahanian S, Azadeh M, Anoshirvan K. The association of food consumption and nutrient intake with endometriosis risk in iranian women: a case-control study. Int J reproductive Biomed. 2019;17(9):661–70.

    Google Scholar 

  19. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, Xie C, Ma K, Shang K, Wang WJCid. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. 2020, 71(15):762–8.

  20. World Health Organization. Regional Office for the Eastern M: WHO interim guidance note: health system response to COVID-19 in the context of internally displaced persons, refugees, migrants and returnees the Eastern Mediterranean Region: 7 April 2020. Cairo:World Health Organization. Regional Office for the Eastern Mediterranean; 2020.

  21. Makris K, Spanou LJTcbr. Acute kidney injury: definition, pathophysiology and clinical phenotypes. 2016, 37(2):85.

  22. Chen S, Li J, Liu Z, Chen D, Zhou L, Hu D, Li M, Long W, Huang Y, Huang J, et al. Comparing the value of cystatin C and serum creatinine for evaluating the renal function and Predicting the prognosis of COVID-19 patients. Front Pharmacol. 2021;12:587816.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Yang Z, Shi J, He Z, Lü Y, Xu Q, Ye C, Chen S, Tang B, Yin K, Lu Y, et al. Predictors for imaging progression on chest CT from coronavirus disease 2019 (COVID-19) patients. Aging. 2020;12(7):6037–48.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Bavishi AA, Mylvaganam RJ, Agarwal R, Avery RJ, Cuttica MJ. Timing of Intubation in Coronavirus Disease 2019: a study of Ventilator mechanics, imaging, findings, and outcomes. Crit care explorations. 2021;3(5):e0415.

    Article  Google Scholar 

  25. Frank RC, Mendez SR, Stevenson EK, Guseh JS, Chung M, Silverman MG. Obesity and the risk of intubation or death in patients with Coronavirus Disease 2019. Crit Care Med. 2020;48(11):e1097–101.

    Article  CAS  PubMed  Google Scholar 

  26. Stefan N, Birkenfeld AL, Schulze MB, Ludwig DS. Obesity and impaired metabolic health in patients with COVID-19. Nat reviews Endocrinol. 2020;16(7):341–2.

    Article  CAS  Google Scholar 

  27. Murugan AT, Sharma G. Obesity and respiratory diseases. Chronic Resp Dis. 2008;5(4):233–42.

    Article  CAS  Google Scholar 

  28. Sattar N, McInnes IB, McMurray JJV. Obesity is a risk factor for severe COVID-19 infection: multiple potential mechanisms. Circulation. 2020;142(1):4–6.

    Article  CAS  PubMed  Google Scholar 

  29. Mottaghi A, Mirmiran P, Pourvali K, Tahmasbpour Z, Azizi F. Incidence and prevalence of childhood obesity in Tehran, Iran in 2011. Iran J public health. 2017;46(10):1395–403.

    PubMed  PubMed Central  Google Scholar 

  30. Kafan S, Vajargah KT, Sheikhvatan M, Tabrizi G, Salimzadeh A, Montazeri M, Majidi F, Maghuli N, Pazoki MJA, Medicine P. Predicting risk score for mechanical ventilation in hospitalized adult patients suffering from COVID-19. 2021, 11(2).

  31. Herold T, Jurinovic V, Arnreich C, Lipworth BJ, Hellmuth JC, von Bergwelt-Baildon M, Klein M, Weinberger TJJoA, Immunology C. Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19. 2020, 146(1):128–36. e124.

  32. Nair PR, Maitra S, Ray BR, Anand RK, Baidya DK, Subramaniam R. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as predictors of the early requirement of mechanical ventilation in COVID-19 patients. Indian J Crit care medicine: peer-reviewed official publication Indian Soc Crit Care Med. 2020;24(11):1143–4.

    Article  Google Scholar 

  33. Pervaiz A, Bashir UPS, Arshad R. Neutrophil to lymphocyte ratio (NLR) can be a predictor of the outcome and the need for mechanical ventilation in patients with covid-19 in Pakistan. Pakistan J Pathol. 2020;31(2):38–41.

    Google Scholar 

  34. Liu J, Liu Y, Xiang P, Pu L, Xiong H, Li C, Zhang M, Tan J, Xu Y, Song RJJotm. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. 2020, 18(1):1–12.

  35. Zhongheng Zhang BL, Xiaoyan Sheng N, Jin. Cystatin C in prediction of Acute kidney Injury: a systemic review and Meta-analysis. Am J Kidney Dis. 2011;58(3):356–65.

    Article  PubMed  Google Scholar 

  36. Li Y, Yang S, Peng D, Zhu HM, Li BY, Yang X, Sun XL, Zhang M. Predictive value of serum cystatin C for risk of mortality in severe and critically ill patients with COVID-19. World J Clin cases. 2020;8(20):4726–34.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Chen D, Sun W, Li J, Wei B, Liu W, Wang X, Song F, Chen L, Yang J, Yu L. Serum Cystatin C and Coronavirus Disease 2019: A Potential Inflammatory Biomarker in Predicting Critical Illness and Mortality for Adult Patients. Mediators of Inflammation 2020, 2020:3764515.

  38. Yang L, Xu D, Tan Y, Li B, Zhu D, Wang J, Sun H, Liu X, Zheng X, Zhu LJFie. Association between the concentration and rangeability of cystatin c and mortality of COVID-19 patients with or without type 2 diabetes mellitus: a retrospective analysis. 2021, 12:713.

  39. Xiang J, Wen J, Yuan X, Xiong S, Zhou X, Liu C, Min XJM. Potential biochemical markers to identify severe cases among COVID-19 patients. 2020.

  40. Henry BM, De Oliveira MHS, Benoit S, Plebani M, Lippi GJCC, Medicine L. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. 2020, 58(7):1021–8.

  41. Su H, Yang M, Wan C, Yi L-X, Tang F, Zhu H-Y, Yi F, Yang H-C, Fogo AB. Nie XJKi: Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. 2020, 98(1):219–27.

  42. Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x, Liu L, Shan H. Lei C-l, Hui DSJNEjom: Clinical characteristics of coronavirus disease 2019 in China. 2020, 382(18):1708–20.

Download references

Acknowledgements

The authors thank nursing and staff at the ICU of Firoozgar hospital.

Author information

Authors and Affiliations

  1. Research Center for Prevention of Cardiovascular diseases, Institute of Endocrinology Metabolism, Iran University of Medical Sciences, Tehran, Iran

    Azadeh Mottaghi

  2. Department of Internal Medicine, Firoozgar Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

    Farzaneh Alipour, Nazanin Alibeik, Ali Kabir & Neda Rahimian

  3. Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran

    Ali Kabir

  4. Department of Nephrology, Firoozgar Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

    Shokoufeh Savaj

  5. Department of Surgery, School of Medicine, Shahid Madani Hospital, Alborz University of Medical Sciences, Karaj, Iran

    Ramin Bozorgmehr

  6. Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran

    Mehdi Nikkhah

Authors
  1. Azadeh Mottaghi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Farzaneh Alipour
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nazanin Alibeik
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ali Kabir
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shokoufeh Savaj
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ramin Bozorgmehr
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mehdi Nikkhah
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Neda Rahimian
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

A.M. and A.K. wrote the main manuscript text and A.K. prepared Tables. All authors reviewed the manuscript.

Corresponding author

Correspondence to Neda Rahimian.

Ethics declarations

Ethics approval and consent to participate

Patients or first-degree relatives of all patients signed informed consent for patient participation in this study, which was approved by the ethical committee of Iran University of Medical Sciences (IR.IUMS.FMD.REC.1401.068). All methods were carried out in accordance with relevant guidelines and regulations.

Consent for publication

Not applicable.

Competing interest

All authors declare no relevant conflicts of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mottaghi, A., Alipour, F., Alibeik, N. et al. Serum cystatin C and inflammatory factors related to COVID-19 consequences. BMC Infect Dis 23, 339 (2023). https://doi.org/10.1186/s12879-023-08258-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12879-023-08258-0

Keywords

BMC Infectious Diseases

ISSN: 1471-2334

Contact us